Additionally, serum Fasn levels increased in patients with hepatitis; moreover, Fasn’s potential to predict liver steatosis in patients with hepatitis C virus has been suggested, as Fasn levels are related to the degree of steatosis (45). This evidence concerns the gene FASN and fatty liver disease.